Search by Drug Name or NDC

    NDC 00187-0004-02 Siliq 210 mg/1 Details

    Siliq 210 mg/1

    Siliq is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch Health US LLC. The primary component is BRODALUMAB.

    Product Information

    NDC 00187-0004
    Product ID 0187-0004_044e3e17-7930-63ae-e063-6294a90acb9b
    Associated GPIs 9025052000E520
    GCN Sequence Number 077139
    GCN Sequence Number Description brodalumab SYRINGE 210 MG/1.5 SUBCUT
    HIC3 L1A
    HIC3 Description ANTIPSORIATIC AGENTS,SYSTEMIC
    GCN 43055
    HICL Sequence Number 044102
    HICL Sequence Number Description BRODALUMAB
    Brand/Generic Brand
    Proprietary Name Siliq
    Proprietary Name Suffix n/a
    Non-Proprietary Name Brodalumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 210
    Active Ingredient Units mg/1
    Substance Name BRODALUMAB
    Labeler Name Bausch Health US LLC
    Pharmaceutical Class Antibodies, Monoclonal [CS], Interleukin 17 Receptor A Antagonists [MoA], Interleukin-17 Receptor A Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761032
    Listing Certified Through 2024-12-31

    Package

    NDC 00187-0004-02 (00187000402)

    NDC Package Code 0187-0004-02
    Billing NDC 00187000402
    Package 2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00)
    Marketing Start Date 2017-02-15
    NDC Exclude Flag N
    Pricing Information N/A